FDA Inspection
Daewoo Pharmaceutical Co., Ltd.Daewoo Pharmaceutical Co., Ltd. – FDA Inspection, Jan 15, 2025
Record Details
This FDA Inspection record concerns Daewoo Pharmaceutical Co., Ltd., with an inspection on January 15, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ceb4bcdf-d411-482c-a9aa-957dc615b70d
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1258203
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Daewoo Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Daewoo Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.